G. Haase, H. Skopnik, S. Bätge and E. C. Böttger, “Cervical Lymphadenitis Caused by Mycobacterium Celatum,” Lancet, Vol. 344, No. 8928, 1994, pp. 1020-1021.
http://dx.doi.org/10.1016/S0140-6736(94)91680-2

has been cited by the following article:

• TITLE: Fatal Pulmonary Mycobacterium Celatum Infection in an Immunocompetent Patient. An Eight-Year Follow-Up of the First Case, a Review of the Literature and a Report of Beta-2 Microglobulin as a Potential Indicator of Disease Severity

  AUTHORS: S. Rustscheff, J. Darelid

  KEYWORDS: Mycobacterium Celatum; Immunocompenent

  JOURNAL NAME: Advances in Infectious Diseases, Vol.3 No.4, December 3, 2013

  ABSTRACT: Setting: Swedish county hospital. Objective: Pulmonary M. celatum infection has been previously described only twice in an immunocompetent individual with no pre-existing chest disease. We describe the first Swedish case report of unusual drug-related complications and review the literature. Discussion: Atypical mycobacteriosis is often difficult to treat. We describe a fatal case of m celatum pneumonia in a previously healthy patient, unusual side effects encountered during her treatment and also the report of the utility of beta-2-microglobulin as a way to measure disease activity in mycobacterial infections. Conclusions: M. celatum may cause fatal pneumonia in previously healthy individuals. Treating the disease may be fraught with difficulty and there is a risk for very severe side effects, all of which must be weighed before taking the decision to treat this disease.